Overview

Ketamine and Prolonged Exposure in PTSD

Status:
Completed
Trial end date:
2019-12-04
Target enrollment:
Participant gender:
Summary
This study aims at investigating the effectiveness of the drug, Ketamine, in combination with Prolonged Exposure (PE) therapy for people suffering from PTSD. Participation in the study includes Ketamine infusions, which occur once a week for three weeks. PE therapy sessions will be scheduled one day after each infusion, and may continue up to 12 weeks. After completely therapy, there will be two monthly follow-up assessment visits.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Minneapolis Veterans Affairs Medical Center
Treatments:
Ketamine